Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 2, 2017 Off

Pfizer launches antifungal drug Cresemba in Spain, Basilea looks at $427 million

By Dino Mustafić

Basilea Pharmaceutica said Thursday its licensing partner Pfizer recently launched the antifungal drug Cresemba (isavuconazole) in Spain. Pfizer is now commercializing…

Tigenix protects its Chron’s disease treatment
November 2, 2017 Off

Tigenix protects its Chron’s disease treatment

By Dino Mustafić

TiGenix has further strengthened its IP protection around the company’s lead product Cx601, intended for the treatment of complex perianal fistulas…

Pharmapack Europe 2018 to showcase evolution and revolution in packaging and drug delivery
November 1, 2017 Off

Pharmapack Europe 2018 to showcase evolution and revolution in packaging and drug delivery

By Dino Mustafić

Pharmapack Europe 2018 today announced the comprehensive event programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition…

Actelion to be delisted from SIX Swiss Exchange in November
October 31, 2017 Off

Actelion to be delisted from SIX Swiss Exchange in November

By Dino Mustafić

Actelion said on Tuesday that, by decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all…

Novartis waits second indication Kymriah to reach more patients
October 31, 2017 Off

Novartis waits second indication Kymriah to reach more patients

By Dino Mustafić

Novartis said on Tuesday that it has submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug…

Mereo BioPharma agrees with AstraZeneca for exclusive license and option to acquire AZD9668
October 30, 2017 Off

Mereo BioPharma agrees with AstraZeneca for exclusive license and option to acquire AZD9668

By Dino Mustafić

Mereo BioPharma has made a deal with AstraZeneca for an exclusive license, including an option to acquire, AZD9668, an oral inhibitor…

Hemogenyx selects LakePharma as its service provider for making CDX bi-specific antibodies
October 30, 2017 Off

Hemogenyx selects LakePharma as its service provider for making CDX bi-specific antibodies

By Dino Mustafić

Hemogenyx Pharmaceuticals has picked LakePharma as its service provider for the development and manufacturing of Hemogenyx’s lead product, CDX bi-specific…

Novartis expands its oncology arm with AAA
October 30, 2017 Off

Novartis expands its oncology arm with AAA

By Dino Mustafić

Novartis said on Monday that it wants to buy Advanced Accelerator Applications (AAA), a radiopharmaceutical company that owns and sells…

Sandoz is seeking approval for use of its biosimilar to Amgen’s Neulasta, EMA to take a look at it
October 27, 2017 Off

Sandoz is seeking approval for use of its biosimilar to Amgen’s Neulasta, EMA to take a look at it

By Dino Mustafić

Novartis division Sandoz has gotten acceptance for its biosimilar to Amgen’s Neulasta by the European Medicines Agency (EMA) for regulatory…

Russian biotechnology company BIOCAD enters the European market
October 26, 2017 Off

Russian biotechnology company BIOCAD enters the European market

By Dino Mustafić

The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there…

Posts pagination

Previous 1 … 3,427 3,428 3,429 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine